[Isolated extremity perfusion with TNF-alpha and melphalan in unresectable soft tissue sarcoma. Indications, principles and technique].
Taeger
G
G
Klinik für Unfallchirurgie, Universitätsklinikum Essen. georg.taeger@uni-essen.de
Ruchholtz
S
S
Niebel
W
W
Müller
S
S
Nast-Kolb
D
D
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001706:Biopsy; D010478:Chemotherapy, Cancer, Regional Perfusion; D003131:Combined Modality Therapy; D003238:Connective Tissue / Q000473:pathology; D005121:Extremities / Q000601:surgery; D006355:Heart-Lung Machine; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods; D008558:Melphalan / Q000008:administration & dosage*; D009336:Necrosis; D009367:Neoplasm Staging; D012509:Sarcoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D012983:Soft Tissue Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage*
D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan